Topical apraclonidine in the diagnosis of suspected Horner Syndrome

Journal of Neuro-Ophthalmology

Volumn 25, Issue 2, 2005, Pages 83-85

  Freedman, Kenn A ^a   Brown, Sandra M ^a,b  

^a TEXAS TECH UNIVERSITY HEALTH SCIENCES CENTER SCHOOL OF MEDICINE   (United States)

^b Cabarrus Eye Center   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA 1 ADRENERGIC RECEPTOR; APRACLONIDINE; COCAINE; NORADRENALIN;

ADULT; ALPHA ADRENERGIC STIMULATION; ANISOCORIA; ARTICLE; CASE REPORT; DENERVATION; DIAGNOSTIC TEST; DRUG EFFECT; DRUG INSTILLATION; DRUG MECHANISM; DRUG RECEPTOR BINDING; HORNER SYNDROME; HUMAN; INTRAOCULAR HYPOTENSION; MALE; MYDRIASIS; PHYSICAL EXAMINATION; POSTOPERATIVE PERIOD; PRESCHOOL CHILD; PRIORITY JOURNAL; SYMPATHETIC NERVE;

ADMINISTRATION, TOPICAL; ADRENERGIC ALPHA-AGONISTS; ADULT; CHILD, PRESCHOOL; CLONIDINE; COCAINE; DOPAMINE UPTAKE INHIBITORS; HORNER SYNDROME; HUMANS; MALE;

EID: 20344366065     PISSN: 10708022     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.WNO.0000165108.31731.36     Document Type: Article

References (9)

1. Walton KA, Buono LM. Horner Syndrome. Curr Opin Ophthalmol 2003;14:357-63.
2. Thompson HS, Miller NR. Disorders of pupillary function, accommodation, and lacrimation. In: Miller NR, Newman NJ, eds. Walsh and Hoyt's Clinical Neuro-Ophthalmology. Baltimore: Williams and Wilkins; 1998:961-1040.
3. Wilhelm H, Ochsner H, Kopycziok E, Trauzettel-Klosinski S, et al. Horner's syndrome: a retrospective analysis of 90 cases and recommendations for clinical handling. Ger J Ophthalmol 1992;1:96-102.
4. Ritz MC, Cone EJ, Kuhar MJ. Cocaine inhibition of ligand binding at dopamine, norepinephrine and serotonin transporters: a structure-activity study. Life Sci 1990;46:635-45.
5. Abrams DA, Robin AL, Pollack IP, deFaller JM, et al. The safety and efficacy of topical 1% ALO 2145 (p-aminoclonidine hydrochloride) in normal volunteers. Arch Ophthalmol 1987;105:1205-7.
6. Ramsay DA. Dilute solutions of phenylephrine and pilocarpine in the diagnosis of disordered autonomic innervation of the iris. Observations in normal subjects, and in the syndromes of Horner and Holmes-Adie. J Neurol Sci 1986;73:125-34.
7. Morales J, Brown SM, Abdul-Rahim AS, Crosson CE. Ocular effects of apraclonidine in Horner Syndrome. Arch Ophthalmol 2000;118:951-4.
8. Brown SM, Aouchiche R, Freedman KA. The utility of 0.5% apraclonidine in the diagnosis of Horner Syndrome. Arch Ophthalmol 2003;121:1201-3.
9. Bartlett JD, Jaanus SD, eds. Clinical Ocular Pharmacology, Fourth ed. Boston: Butterworth-Heinemann; 2001.